Business Services
Medical
Pharmaceutical

Aceto

$0.161
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.0045 (-2.74%) Today
+$0.001 (0.63%) After Hours

Why Robinhood?

You can buy or sell Aceto and other stocks, options, ETFs, and crypto commission-free!

About

Aceto Corp. engages in the development, marketing, sale, and distribution of chemical compounds used in the pharmaceutical, nutraceutical, agricultural, coatings, and industrial chemical industries. It operates through the following segments: Human Health, Pharmaceutical Ingredients, and Performance Chemicals. Read More The Human Health segment develops and sells finished dosage form generic drugs and nutraceutical products. The Pharmaceutical Ingredients segment supplies active pharmaceutical ingredients and pharmaceutical intermediates. The Performance Chemicals segment comprises of specialty chemicals and agricultural protection products. The company was founded in 1947 and is headquartered in Port Washington, NY.

Employees
315
Headquarters
Port Washington, New York
Founded
1947
Market Cap
5.07M
Price-Earnings Ratio
Dividend Yield
6.12
Average Volume
1.21M
High Today
$0.1707
Low Today
$0.1583
Open Price
$0.1707
Volume
522.90K
52 Week High
$7.64
52 Week Low
$0.1401

Collections

Business Services
Medical
Pharmaceutical
Chemicals
Advertising and Marketing
Health
US
North America

News

TradingNewsNowMar 21

Present Technicals: Aceto Corporation (NASDAQ: ACET)

Aceto Corporation is part of the healthcare sector and is in the drug manufacturers industry. The company CEO is William C. Kennally. Aceto Corp is engaged in the marketing, sells and distribution of finished dosage form generic pharmaceuticals, nutraceutical products, pharmaceutical active ingredients and intermediates, and specialty performance chemicals. Previous Intraday Trading Performance: The ACET stock showed a previous change of -1.39% with an open at 0.18 and a close of 0.18. It reached an intra...

1,235
DealStreetAsiaMar 11

Redington, Suven Life, CPPIB, Gourmet Investments in M&A news

In the latest M&A deals, Redington India on Friday said it has acquired 90 per cent stake in Auroma Logistics while Suven Life Sciences has entered into an asset purchase agreement to buy assets of Aceto Corporation’s Rising Pharmaceuticals and its subsidiaries.

1,322
Markets InsiderMar 7

ACETO Enters into “Stalking Horse” Agreement to Sell Rising Pharmaceuticals

PORT WASHINGTON, N.Y., March 07, 2019 (GLOBE NEWSWIRE) -- ACETO Corporation (Nasdaq: ACET), an international company engaged in the development, marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, announced today that it has entered into a “stalking-horse” asset purchase agreement with Shore Suven Pharma, Inc.

1,730

Earnings

-$0.59
-$0.25
$0.10
$0.44
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Expected Mar 29, After Hours
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.